You have 9 free searches left this month | for more free features.

Leukemia, B-Cell

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma, Squamous Cell, Head and Neck Tumors, Oropharyngeal Tumors Trial in United States (radiation, drug, procedure)

Completed
  • Carcinoma, Squamous Cell
  • +2 more
  • Intensity Modulated Radiotherapy (IMRT)
  • +2 more
  • Colorado Springs, Colorado
  • +4 more
Dec 7, 2021

NSCLC Trial in Worldwide (Lazertinib 240 mg/160 mg, Gefitinib 250 mg, Lazertinib-matching 240 mg/160 mg)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Lazertinib 240 mg/160 mg
  • +3 more
  • Woolloongabba, Queensland, Australia
  • +79 more
Nov 1, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +5 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jul 14, 2022

Brain Metastases, Renal Cell Carcinoma Trial in Houston (Nivolumab, Ipilimumab, Cabozantinib)

Not yet recruiting
  • Brain Metastases
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Extranodal NK/T-cell Lymphoma Trial (Sugemalimab, Placebo, Pegaspargase)

Not yet recruiting
  • Extranodal NK/T-cell Lymphoma
  • Sugemalimab
  • +4 more
  • (no location specified)
Jan 17, 2023

AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

Not yet recruiting
  • AML, Adult
  • +4 more
  • Amiens, France
  • +19 more
Sep 1, 2023

Locally Advanced Unresectable or Metastatic Solid Tumors Trial in Benowa (IBI343)

Not yet recruiting
  • Locally Advanced Unresectable or Metastatic Solid Tumors
  • Benowa, Queensland, Australia
    Pindara Private Hospital
Jul 11, 2022

Healthy Trial in Rochester (Dasatinib, Quercetin, Fisetin)

Recruiting
  • Healthy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jul 22, 2022

Head Neck Cancer, Human Papilloma Virus Trial in United States (MEDI0457, CELLECTRA®5P device, Durvalumab)

Completed
  • Head and Neck Cancer
  • Human Papilloma Virus
  • San Francisco, California
  • +13 more
Aug 3, 2022

Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in United States

Suspended
  • Recurrent Ovarian High Grade Serous Adenocarcinoma
  • Recurrent Platinum-Resistant Ovarian Carcinoma
  • Phoenix, Arizona
  • +8 more
Jul 26, 2022

Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer Trial in United States (PF-07104091 monotherapy dose escalation,

Recruiting
  • Small Cell Lung Cancer
  • +4 more
  • PF-07104091 monotherapy dose escalation
  • +8 more
  • Clive, Iowa
  • +22 more
Apr 26, 2022

Social-environmental, Psychosocial, Behavioral, Clinical and

Recruiting
  • Chronic Viral Hepatitis
  • Hepatitis B Infection
  • Interview
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Nov 2, 2021

Clear Cell Sarcoma of Soft Tissue Trial in Wuhan (18F-PFPN)

Recruiting
  • Clear Cell Sarcoma of Soft Tissue
  • Wuhan, Hubei, China
    China, Hubei Province
Jul 19, 2023

Acute Myeloid Leukemia, in Relapse, Recurrent Adult Acute Myeloid Leukemia Trial in Boston (GO-203-2c, GO-203-2c + Decitabine)

Active, not recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Recurrent Adult Acute Myeloid Leukemia
  • Boston, Massachusetts
  • +1 more
Jan 25, 2022

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial (Pulmonary Artery-First Surgical

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Pulmonary Artery-First Surgical Technique
  • Biospecimen Collection
  • (no location specified)
Aug 15, 2022

HIV Trial in United States (MN rgp120/HIV-1 and A244 rgp120/HIV-1, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • MN rgp120/HIV-1 and A244 rgp120/HIV-1
  • +2 more
  • Baltimore, Maryland
  • +3 more
Oct 28, 2021

Solid Tumor and Hematologic Malignancies Trial in United States (MEK162)

Completed
  • Solid Tumor and Hematologic Malignancies
  • Mobile, Alabama
  • +67 more
Feb 2, 2021

Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • intrathecal nivolumab and intrathecal ipilimumab
  • Geneva, Switzerland
  • +2 more
Dec 18, 2022

Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1

Recruiting
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
    • Yiwu, Zhejiang, China
      The Fourth Affiliated Hospital Zhejiang University School of Med
    Mar 27, 2023

    Human Blood Cell Disorders Tissue Bank

    Recruiting
    • Human Blood Cell Disorders
    • Lymphoid, Myeloid and Erythroid Proliferative Disease
      • Manhasset, New York
        The Feinstein Institute for Medical Research
      Jul 6, 2022

      Tumor Tissue Samples From Early-Stage Non-Small Cell Lung Cancer

      Completed
      • Lung Cancer
      • laboratory biomarker analysis
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Aug 16, 2021

      IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP

      Recruiting
      • Nasal Polyps
      • Aspirin-exacerbated Respiratory Disease
      • Non-Interventional
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Jan 5, 2023

      Non Small Cell Lung Cancer (NSCLC) Trial in Milan (Pembrolizumab)

      Active, not recruiting
      • Non Small Cell Lung Cancer (NSCLC)
      • Milan, Italy
        National Cancer Institute
      Jun 8, 2021

      Idiopathic Pulmonary Fibrosis Trial in Beijing, Shanghai (REGEND001, Placebo)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • REGEND001
      • Placebo
      • Beijing, Beijing, China
      • +2 more
      Oct 7, 2023

      Type 1 Diabetes Trial in Milan (Human pancreatic islet transplantation)

      Completed
      • Type 1 Diabetes
      • Human pancreatic islet transplantation
      • Milan, Italy
        Ospedale San Raffaele
      Nov 2, 2020